Metraipolis › archive › dc_ffb0ee7760de

Adverse event reporting of mirtazapine: A disproportionality analysis of FDA adverse event reporting system (FAERS) database from 2004-2024 — Europe PMC PMID:41417795

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41417795
DOI
10.1371/journal.pone.0328191
License (as archived)
solo-consultazione
Archived
2026-10-07T12:00:08.101Z
SHA-256 of the archived text
449dd4ddb3c8440b5fc3c6db67f81a72d3686991e523d7cf34ba340c1b57eee1
Stable URL of this page
https://metraipolis.com/documento/dc_ffb0ee7760de

How to cite

Adverse event reporting of mirtazapine: A disproportionality analysis of FDA adverse event reporting system (FAERS) database from 2004-2024 — Europe PMC PMID:41417795 — Europe PMC (en), https://europepmc.org/article/MED/41417795 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffb0ee7760de (Metraipolis archive dc_ffb0ee7760de, sha256 449dd4ddb3c8440b5fc3c6db67f81a72d3686991e523d7cf34ba340c1b57eee1)
BibTeX
@misc{dcffb0ee7760de,
  title = {Adverse event reporting of mirtazapine: A disproportionality analysis of FDA adverse event reporting system (FAERS) database from 2004-2024 — Europe PMC PMID:41417795},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41417795},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffb0ee7760de; sha256 449dd4ddb3c8440b5fc3c6db67f81a72d3686991e523d7cf34ba340c1b57eee1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41417795. Agents can read the archived copy with the MCP tool read_document.